Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long-term Study of Cariprazine in Patients With Schizophrenia

ClinicalTrials.gov ID: NCT01104792

Public ClinicalTrials.gov record NCT01104792. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 12:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of the Long-term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia

Study identification

NCT ID
NCT01104792
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Forest Laboratories
Industry
Enrollment
752 participants

Conditions and interventions

Conditions

Interventions

  • Cariprazine Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 30, 2010
Primary completion
Jan 30, 2013
Completion
Jan 30, 2013
Last update posted
Jul 25, 2019

2010 – 2013

United States locations

U.S. sites
39
U.S. states
17
U.S. cities
33
Facility City State ZIP Site status
Forest Investigative Site 072 Little Rock Arkansas 72201
Forest Investigative Site 021 Little Rock Arkansas 72211
Forest Investigative Site 086 Little Rock Arkansas 72211
Forest Investigative Site 014 Springdale Arkansas 72764
Forest Investigative Site 080 Carson California 90746
Forest Investigative Site 079 Cerritos California 90703
Forest Investigative Site 048 Costa Mesa California 92626
Forest Investigative Site 070 Costa Mesa California 92626
Forest Investigative Site 022 Garden Grove California 92845
Forest Investigative Site 083 Garden Grove California 92845
Forest Investigative Site 050 Long Beach California 90813
Forest Investigative Site 006 Oceanside California 92056
Forest Investigative Site 003 Riverside California 92506
Forest Investigative Site 016 San Diego California 92123
Forest Investigative Site 073 Santa Ana California 92701
Forest Investigative Site 071 New Britain Connecticut 06050
Forest Investigative Site 002 Bradenton Florida 34208
Forest Investigative Site 041 Kissimmee Florida 34741
Forest Investigative Site 082 North Miami Florida 33161
Forest Investigative Site 055 Atlanta Georgia 30308
Forest Investigative Site 087 Atlanta Georgia 30308
Forest Investigative Site 012 Honolulu Hawaii 96813
Forest Investigative Site 018 Chicago Illinois 60640
Forest Investigative Site 008 Hoffman Estates Illinois 60169
Forest Investigative Site 044 Rockville Maryland 20850
Forest Investigative Site 007 Flowood Mississippi 39232
Forest Investigative Site 017 Creve Coeur Missouri 63141
Forest Investigative Site 076 Saint Charles Missouri 63301
Forest Investigative Site 045 St Louis Missouri 63118
Forest Investigative Site 052 Las Vegas Nevada 89102
Forest Investigative Site 004 Willingboro New Jersey 08046
Forest Investigative Site 040 Cedarhurst New York 11516
Forest Investigative Site 019 Willoughby Ohio 44094
Forest Investigative Site 077 Philadelphia Pennsylvania 19131
Forest Investigative Site 047 Philadelphia Pennsylvania 19139
Forest Investigative Site 074 Austin Texas 78756
Forest Investigative Site 084 DeSoto Texas 75115
Forest Investigative Site 043 Irving Texas 75062
Forest Investigative Site 078 Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01104792, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 25, 2019 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01104792 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →